NAT10 Protein Identified as Driver of Follicular Atresia
Researchers found that inhibiting the NAT10 protein with Remodelin may help improve reproductive efficiency in mammals.
Updated on Oct. 25, 2026 in Biotech
Scientists have identified the NAT10 protein as a key driver of follicular atresia, a process contributing to ovarian dysfunction. Inhibiting this protein with the drug Remodelin may offer a new path for treating infertility.
Why it matters
Understanding the mechanisms behind follicular atresia provides insight into how ovarian function declines. Targeting this pathway could lead to new therapies for managing subfertility and infertility issues.
The study demonstrates that NAT10 catalyzes the ac4C modification of Tnc mRNA, increasing its stability. This process triggers Tnc protein-mediated degradation of Parkin, effectively blocking the mitophagy pathway and increasing oxidative stress.
The players
NAT10
This protein functions as a critical driver of follicular atresia and promotes oxidative stress by inhibiting the mitophagy pathway in granulosa cells.
Remodelin
This chemical compound serves as a specific inhibitor of NAT10 and has shown potential in mitigating the progression of follicular atresia.
The details
The research reveals that NAT10 enhances the stability of Tnc mRNA, which in turn leads to the degradation of Parkin. By using Remodelin to specifically inhibit NAT10, researchers were able to hinder follicular atresia in vivo and improve reproductive efficiency.
Timeline
The study findings were published on October 25, 2026.
The Tech Race
This study shifts the trajectory of reproductive biotechnology by moving beyond purely genetic markers to investigate the precise role of RNA modifications. It marks a departure from traditional hormone-based treatments by focusing on the molecular machinery that governs follicular cell health.
While currently a preclinical discovery, this research provides a foundation for future therapeutic interventions that could assist patients struggling with infertility. These developments may eventually lead to more targeted drug-based treatments rather than invasive procedures.
The takeaway
The study highlights that targeting specific protein interactions can successfully regulate cellular pathways involved in reproduction. Further research will be essential to translate these findings into effective and safe treatments for human reproductive health.
Further reading
Learn more about the latest innovations in this field in the Biotech section.
Source note: This article includes information reported by Nature.
